Turkesterone vs Ostarine

Turkesterone wins for safety profile (non-hormonal, no suppression), zero PCT requirement, female-friendliness, and lowest risk of virilization or liver strain. It's the cleanest option for anyone wanting incremental gains or insurance during a bridge or natty recomp, especially when sourcing is tight or maximum conservatism is needed.

Ostarine wins for raw potency, consistently higher lean-mass retention in a deficit, clinical data backing, clear dose-response, and easier access to pharmaceutical-grade material on the grey market. Lean-preservation during aggressive cuts, contest prep, or any scenario demanding measurable effect size favors ostarine.

Pick Turkesterone if:

• The protocol requires a truly non-hormonal, suppression-free anabolic (e.g. between AAS or SARM cycles, or for users uninterested in running any HPTA-suppressing agent)
• A safety-first protocol is the main concern — no liver strain, no suppression, no PCT
• Female or risk-averse protocols where androgenic/virilization risks must be minimized
• A low-stakes natty recomp or bridge stack with creatine, ashwagandha, and other adaptogens
• Sourcing issues make reliable SARMs access questionable, or compliance risk is a factor

Pick Ostarine if:

• The goal is maximized lean-mass retention (or modest gain) in a caloric deficit, e.g. contest prep, mini cuts, or aggressive recomps
• A clear, dose-responsive effect is needed — user wants reliable, pharmacologically significant results
• Protocol is stacked with other SARMs or mild orals and non-trivial suppression (plus PCT) is acceptable
• Previous cycles with natty or plant-based anabolics were underwhelming in potency
• Prepared to manage mild suppression (short PCT if needed) and accept mild HDL drop